rs142179562
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_003705.5(SLC25A12):c.1458G>A(p.Ala486=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00466 in 1,613,902 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0039 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 25 hom. )
Consequence
SLC25A12
NM_003705.5 synonymous
NM_003705.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0250
Genes affected
SLC25A12 (HGNC:10982): (solute carrier family 25 member 12) This gene encodes a calcium-binding mitochondrial carrier protein. The encoded protein localizes to the mitochondria and is involved in the exchange of aspartate for glutamate across the inner mitochondrial membrane. Polymorphisms in this gene may be associated with autism, and mutations in this gene may also be a cause of global cerebral hypomyelination. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 2-171791578-C-T is Benign according to our data. Variant chr2-171791578-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 332338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.025 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00391 (595/152204) while in subpopulation NFE AF= 0.00576 (392/68010). AF 95% confidence interval is 0.00529. There are 2 homozygotes in gnomad4. There are 304 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A12 | NM_003705.5 | c.1458G>A | p.Ala486= | synonymous_variant | 15/18 | ENST00000422440.7 | NP_003696.2 | |
SLC25A12 | XM_047446142.1 | c.1185G>A | p.Ala395= | synonymous_variant | 13/16 | XP_047302098.1 | ||
SLC25A12 | NR_047549.2 | n.1372G>A | non_coding_transcript_exon_variant | 14/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A12 | ENST00000422440.7 | c.1458G>A | p.Ala486= | synonymous_variant | 15/18 | 1 | NM_003705.5 | ENSP00000388658 | P1 | |
SLC25A12 | ENST00000263812.8 | c.*1078G>A | 3_prime_UTR_variant, NMD_transcript_variant | 14/17 | 2 | ENSP00000263812 |
Frequencies
GnomAD3 genomes AF: 0.00391 AC: 595AN: 152086Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
595
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00357 AC: 898AN: 251458Hom.: 3 AF XY: 0.00368 AC XY: 500AN XY: 135902
GnomAD3 exomes
AF:
AC:
898
AN:
251458
Hom.:
AF XY:
AC XY:
500
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00473 AC: 6921AN: 1461698Hom.: 25 Cov.: 31 AF XY: 0.00464 AC XY: 3375AN XY: 727166
GnomAD4 exome
AF:
AC:
6921
AN:
1461698
Hom.:
Cov.:
31
AF XY:
AC XY:
3375
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00391 AC: 595AN: 152204Hom.: 2 Cov.: 32 AF XY: 0.00409 AC XY: 304AN XY: 74410
GnomAD4 genome
AF:
AC:
595
AN:
152204
Hom.:
Cov.:
32
AF XY:
AC XY:
304
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | SLC25A12: BP4, BP7 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
SLC25A12-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 01, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at